tributyl phosphate has been researched along with Hyperplasia in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brine, DR; Gerhart, JM; Henrich, RT; Marr, MC; Myers, CB; Seely, JC; Tyl, RW | 1 |
Arnold, LL; Cano, M; Christenson, WR; Cohen, SM; St John, MK; Wahle, BS | 1 |
Auletta, CS; Richter, WR; Weiner, ML | 1 |
Auletta, CS; Kotkoskie, LA; Richter, WR; Saulog, T | 1 |
4 other study(ies) available for tributyl phosphate and Hyperplasia
Article | Year |
---|---|
Two-generation reproductive toxicity study of dietary tributyl phosphate in CD rats.
Topics: Animals; Body Weight; Diet; Female; Hyperplasia; Litter Size; Male; Organ Size; Organophosphates; Pregnancy; Rats; Rats, Sprague-Dawley; Reproduction; Sex Ratio; Sexual Behavior, Animal | 1997 |
Tributyl phosphate effects on urine and bladder epithelium in male Sprague-Dawley rats.
Topics: Administration, Oral; Ammonium Chloride; Animals; Body Weight; Carcinogens; Creatinine; Dose-Response Relationship, Drug; Hydrogen-Ion Concentration; Hyperplasia; Male; Necrosis; Organ Size; Organophosphates; Radiation-Protective Agents; Rats; Rats, Sprague-Dawley; Urinary Bladder; Urine; Urothelium | 1997 |
A dietary toxicity/oncogenicity study of tributyl phosphate in the rat.
Topics: Administration, Oral; Animals; Carcinogens; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Dose-Response Relationship, Drug; Eating; Female; Hyperplasia; Male; No-Observed-Adverse-Effect Level; Organophosphates; Papilloma; Rats; Rats, Sprague-Dawley; Sex Factors; Survival Analysis; Urinary Bladder; Urinary Bladder Neoplasms; Urine; Weight Gain | 1998 |
A dietary oncogenicity study of tributyl phosphate in the CD-1 mouse.
Topics: Adenoma, Liver Cell; Administration, Oral; Animals; Carcinogens; Dose-Response Relationship, Drug; Female; Hyperplasia; Liver; Liver Neoplasms, Experimental; Male; Mice; No-Observed-Adverse-Effect Level; Organ Size; Organophosphates; Sex Factors; Urinary Bladder; Weight Gain | 1998 |